Neonatal Seizures
14
0
0
7
Key Insights
Highlights
Success Rate
70% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 64/100
21.4%
3 terminated out of 14 trials
70.0%
-16.5% vs benchmark
21%
3 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
An Observational Study of the NeuroBell EEG Monitor
Levetiracetam Versus Phenobarbitone for the Treatment of Neonatal Seizures in a Tertiary Care Hospital.
Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study
Treatment of Seizures in Neonate With HIE
Patterns of Neonatal Seizures
Levetiracetam Treatment of Neonatal Seizures
EAGLET: EEG vs aEEG to Improve the Diagnosis of neonataL Seizures and Epilepsy
Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study
Efficacy of Intravenous Levetiracetam in Neonatal Seizures
Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG
Prophylactic Phenobarbital After Neonatal Seizures
NEMO1:NEonatal Seizure Using Medication Off-patent
ANSeR- The Algorithm for Neonatal Seizure Recognition Study
Efficacy of Keppra for Neonatal Seizures